Abstract

Pancreatic cysts are an increasingly recognized clinical entity, found in up to 13% of patients undergoing magnetic resonance imaging (MRI) with no history of pancreatic disease. The differential diagnosis of pancreatic cystic lesions is wide. The majority of these lesions are benign, but detection of mucinous neoplasms (intraductal papillary mucinous neoplasms and mucinous cystic neoplasms) is important because these cysts may be malignant or have malignant potential. Pancreatic cysts thus represent an important and increasing disease burden. Furthermore, they can pose difficult diagnostic and management problems; that is, how to accurately predict which lesions contain high-grade dysplasia or pancreatic ductal adenocarcinoma and require resection versus those that can be followed safely by interval imaging or require no further follow-up. Despite advances in computed tomography (CT) and MRI, the ability of cross-sectional imaging to identify the exact nature of a cyst remains limited. Endoscopic ultrasonography (EUS) is ideally suited to image pancreatic lesions because of its high resolution and ability to sample cystic lesions. The diagnostic accuracy of EUS based on morphology alone is limited. A combination of EUS features, fluid cytology, carcinoembryonic antigen level, and newer techniques including molecular markers can be helpful in answering these questions. Accurate diagnosis and management of pancreatic cystic lesions requires careful evaluation of the clinical setting, other imaging modalities, and multidisciplinary collaboration. This chapter discusses the different types of pancreatic cysts, their endosonographic features, and the role of EUS-guided cyst sampling. A diagnostic approach to patients with pancreatic cysts is also described.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call